Sox2, but not Oct4 or Nanog, overexpression was found in breast cancers and nuclear reprogramming of ER-positive Michigan Cancer Foundation-7 (MCF-7) cells yielded Sox2-overexpressing cells with enhanced BCSC characteristics. The gene discussed is ESR1; the disease is breast carcinoma.